Categories
Nimbus and Nimbus II infusion pumps may experience one or more issues that can cause severe patient injury and death.
Categories
FDA Approves New Treatment for Uncomplicated Urinary Tract Infections
FDA Approves New Treatment for Uncomplicated Urinary Tract Infections
http://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-uncomplicated-urinary-tract-infections
Categories
DeRoyal Industries, Inc. Recalls Tracecarts Containing 16FR Urine Meter Foley Under Recall by Nurse Assist
DeRoyal is recalling Surgical Tracecarts with Nurse Assist 16FR Silver Urine Meter Foley due to sterility concerns. Other items in the tracecart are unaffected.
Categories
FDA Roundup: April 23, 2024
FDA Roundup: April 23, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-april-23-2024
Categories
STOP CLOPEZ CORP Issues Voluntary Worldwide Recall of Schwinnng Capsules Due to the Presence of Undeclared Nortadalafil
Hollywood, FL, US, STOP CLOPEZ CORP is voluntarily recalling one lot of Schwinnng capsules to the consumer level. FDA analysis has found the Schwinnng products to contain Nortadalafil. Nortadalafil is an active drug ingredient known for the treatment of male erectile dysfunction. The presence of Nor
Categories
Dr. Reddy’s Issues Voluntary Nationwide Recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg Due to Sub-Potency
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced that it is voluntarily recalling six (6) lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer leve
Categories
FDA Roundup: April 19, 2024
FDA Roundup: April 19, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-april-19-2024
Categories
Boston Scientific Recalls Obsidio Conformable Embolic for Increased Bowel Ischemia Risk When Used for Lower GI Bleeding
Obsidio Embolic may cause bowel ischemia if used with the aliquot technique to address lower GI bleeding.
Categories
Fresenius Kabi USA, LLC Recalls Ivenix Infusion Pump LVP Software for Anomalies That Have the Potential to Cause Serious Patient Harm or Death
Fresenius Kabi is recalling Ivenix Infusion System (IIS), LVP, due to several software issues that could cause serious harm or death to patients.
Categories
FDA Roundup: April 16, 2024
FDA Roundup: April 16, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-april-16-2024